Hemispherian AS announced the initiation of a Phase 1/2a clinical trial testing GLIX1 in patients with recurrent and progressive glioblastoma ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE